BULEVIRTIDE (Hepcludex ®)

Clinical Indication

Treating chronic hepatitis D

Date of classification

September 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.